Why is the US allowing UAE to import Nvidia AI chips?
What caused the massive Ford SUV brake recall?
How will Trump's Middle East deals impact US tech?
Why are Starbucks employees striking over dress code?
How did Dick’s Sporting Goods' Foot Locker deal affect stock?
What led to UnitedHealth’s Medicare fraud investigation?
Why is California facing a large budget deficit?
How is AI reshaping investments in Saudi Arabia?
What caused layoffs at Microsoft despite earnings beat?
GSK to buy experimental MASH drug for $1.2B upfront
statnews.com/2025/05/14/gsk-mash-liver-disease-boston-pharmaceuticals
LONDON — GSK said Wednesday it would purchase an experimental liver disease medicine from Boston Pharmaceuticals for $1.2 billion upfront, seeking to build up its pipeline of future medicines.
The drug, called efimosfermin, is in development to treat a liver condition called MASH, an…
This story appeared on statnews.com, 2025-05-14 21:55:38.799000.